Related references
Note: Only part of the references are listed.A Structural and Functional Acromegaly Classification
Daniel Cuevas-Ramos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
Philippe J. Caron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Stereotactic Radiosurgery for Acromegaly
Cheng-Chia Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
Andrea Giustina et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas in 130 Patients
Manouchehr Shirvani et al.
WORLD NEUROSURGERY (2014)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
Monica R. Gadelha et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
THE ROLE OF TEMOZOLOMIDE IN THE TREATMENT OF A PATIENT WITH A PURE SILENT PITUITARY SOMATOTROPH CARCINOMA
Leonardo Vieira Neto et al.
ENDOCRINE PRACTICE (2013)
Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
Robert M. Starke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria
Derya Burcu Hazer et al.
JOURNAL OF NEUROSURGERY (2013)
Long-Term Follow-Up of Growth Hormone-Producing Pituitary Carcinoma With Multiple Spinal Metastases Following Multiple Surgeries: Case Report
Toshihide Tanaka et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
Jessica Brzana et al.
PITUITARY (2013)
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
Gerald Raverot et al.
CLINICAL ENDOCRINOLOGY (2012)
Acromegaly surgery in Manchester revisited - The impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission
Yi Yuen Wang et al.
CLINICAL ENDOCRINOLOGY (2012)
Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
Clinicopathologic correlates of giant pituitary adenomas
Geeta Chacko et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide
Raquel S. Jallad et al.
NEUROENDOCRINOLOGY (2009)
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Raquel S. Jallad et al.
CLINICAL ENDOCRINOLOGY (2007)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
R Cozzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution
RS Jallad et al.
CLINICAL ENDOCRINOLOGY (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs
P Petrossians et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Primary medical therapy for acromegaly: An open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size
JS Bevan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Transsphenoidal surgery for acromegaly: Endocrinological follow-up of 98 patients
I Shimon et al.
NEUROSURGERY (2001)
Share Paper
